Fungal infections in the immunocompromised host
- PMID: 11142705
- DOI: 10.1590/s0074-02762000000700025
Fungal infections in the immunocompromised host
Abstract
In recent years many remarkable changes occurred in our way of life, producing opportunities for microbes. All these changes are related to the recent emergence of previously unrecognized diseases, or the resurgence of diseases that, at least in developed countries, were thought to be under control. This concept is reviewed regarding fungal infections and their agents in the immunocompromised host. The changing pattern of these infections, the portals of entry of fungi into the human host, fungal pathogenicity and the main predisposing factors are analyzed. Opportunistic fungal infections in cancer, organ transplant and acquired immunodeficiency syndrome patients are reviewed, specially candidiasis and aspergillosis.
Similar articles
-
Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.Drugs. 1995 Oct;50(4):658-90. doi: 10.2165/00003495-199550040-00007. Drugs. 1995. PMID: 8536553 Review.
-
Changing patterns and trends in systemic fungal infections.J Antimicrob Chemother. 2005 Sep;56 Suppl 1:i5-i11. doi: 10.1093/jac/dki218. J Antimicrob Chemother. 2005. PMID: 16120635 Review.
-
[Yeast infections in patients with immunologic disorders].Ned Tijdschr Geneeskd. 1995 Jul 15;139(28):1430-6. Ned Tijdschr Geneeskd. 1995. PMID: 7623929 Review. Dutch. No abstract available.
-
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.Clin Infect Dis. 2002 Jan 1;34(1):7-14. doi: 10.1086/323335. Epub 2001 Nov 26. Clin Infect Dis. 2002. PMID: 11731939
-
Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review.Clin Infect Dis. 1992 Mar;14 Suppl 1:S43-53. doi: 10.1093/clinids/14.supplement_1.s43. Clin Infect Dis. 1992. PMID: 1562695 Review.
Cited by
-
Fungal Opportunistic Pneumonias in HIV/AIDS Patients: An Indian Tertiary Care Experience.J Clin Diagn Res. 2017 Feb;11(2):DC14-DC19. doi: 10.7860/JCDR/2017/24219.9277. Epub 2017 Feb 1. J Clin Diagn Res. 2017. PMID: 28384860 Free PMC article.
-
Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi.Mediators Inflamm. 2017;2017:9870679. doi: 10.1155/2017/9870679. Epub 2017 Jun 13. Mediators Inflamm. 2017. PMID: 28694566 Free PMC article. Review.
-
The Plant Defensin NaD1 Enters the Cytoplasm of Candida Albicans via Endocytosis.J Fungi (Basel). 2018 Feb 6;4(1):20. doi: 10.3390/jof4010020. J Fungi (Basel). 2018. PMID: 29415460 Free PMC article.
-
Portal Dissemination of Fusarium graminearum in a Patient with Acute Lymphoblastic Leukemia and Febrile Neutropenia.Infect Dis Rep. 2021 Jan 1;13(1):11-17. doi: 10.3390/idr13010002. Infect Dis Rep. 2021. PMID: 33401374 Free PMC article.
-
Potato dextrose agar antifungal susceptibility testing for yeasts and molds: evaluation of phosphate effect on antifungal activity of CMT-3.Antimicrob Agents Chemother. 2002 May;46(5):1455-61. doi: 10.1128/AAC.46.5.1455-1461.2002. Antimicrob Agents Chemother. 2002. PMID: 11959582 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical